GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Pharma Has Recovered From the 'Patent Cliff'

Sun 26 May 13 | 10:52 PM ET
Peter Wilmshurst, Portfolio Manager, Templeton Global Equity Group at Franklin Templeton Investments tells CNBC's Cash Flow why he likes pharmaceutical stocks at the moment.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Go
Displaying results for: Latest Video | US